Total Credits: 1 including 1 AOA Category 1-A Credit(s)
This lecture was presented as part of the 2023 IOA Virtual Spring Update by Dr. Jasser Khairallah.
Learning Objectives:
Faculty Disclosure Declaration Statement
This presenter has no conflict of interest or disclosure to declare of any financial interest or other relationship with any commercial entities discussed in this educational presentation.
Accreditation Statement
This educational presentation was developed according to the planning, design, implementation and evaluation standards of the accreditation requirements for category 1 CME sponsors of the American Osteopathic Association (AOA). The Indiana Osteopathic Association (IOA) is accredited by the AOA to provide osteopathic continuing medical education for physicians.
Grievance Policy Statement
"It is the policy of the IOA that any physician dissatisfied with the CME program will be issued a refund upon request, and no CME credits will be reported to the AOA. Complaints on Evaluation Forms also are taken into consideration when planning future CME programs and may lead to changes in the format or content." If you have any questions or concerns about this educational experience, you may call the IOA office at (317) 926-3009 or send an email message to info@inosteo.org. All questions or concerns will be addressed promptly.
| Urine Drug Screen Mimickers | Available after Purchase | ||
Dr. Jasser Khairallah is double boarded in Family Medicine and Addiction Medicine. He completed his medical training at the Kirksville College of Osteopathic Medicine before finishing his family medicine residency at McGaw Medical Center at Northwestern University. He then went on to complete a fellowship in addiction medicine through the department of psychiatry and behavioral health at Stanford University. He simultaneously finished a research fellowship sponsored by SAMHSA, the American Academy of Addiction Psychiatry, and Yale University where his project focused on analyzing for discrepancies in diagnosis and treatment rates for opioid use disorder between patients of color and caucasian patients treated at an FQHC. Dr. Khairallah currently works at Eskenazi Health in Indianapolis where he started their dual-diagnosis program in the primary care setting and serves as faculty in the department of family medicine at the Indiana University School of Medicine. Dr. Khairallah’s clinical interests lie in working with marginalized patients and those identifying as BIPOC who suffer from substance use disorders and co-morbid psychiatric diagnoses. He also has a passion for academic medicine, especially in supporting medical trainees with early interest in mental health. He serves as the director for the addiction medicine summer scholar program through the Indiana University School of Medicine and supports in the clinical education of third and fourth year medical students at the Marian University School of Osteopathic Medicine.